PD-1 limits the activity of T cells in the tumor via its ligand, programmed death-ligand 1 (PD-L1), expressed on tumor cells, making PD-1–PD-L1 interaction the major immune suppressive mechanism in tumor tissue. This evidence concerns the gene CD274 and neoplasm.